GLYCOVISION Trademark

Trademark Overview


On Wednesday, January 4, 2023, a trademark application was filed for GLYCOVISION with the United States Patent and Trademark Office. The USPTO has given the GLYCOVISION trademark a serial number of 97741761. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, May 29, 2025. This trademark is owned by Venn Biosciences Corporation. The GLYCOVISION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research services; scientific research, namely, identifying biomarkers for specific diseases; scientific research analysis services for blood and other bodily fluids, specifically, blood, bodily fluid, and biological specimen analysis services; scientific, technological, and medical research and data analysis services in the nature of bioanalytical testing services and biomarker discovery services; scientific and medical research in the fields of oncology, mass spectrometry, glycoproteomics, biomarker discovery; scientific, technological, and data analysis services, namely, glycoproteomic research, analysis services in the nature of protein, and a glycoproteomic solution featuring artificial intelligence; scientific and medical laboratory services; medical research services via collecting, analyzing, and reporting glycoproteomic data for blood, bodily fluids, and other biological specimens
glycovision

General Information


Serial Number97741761
Word MarkGLYCOVISION
Filing DateWednesday, January 4, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, May 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesScientific and medical research services; scientific research, namely, identifying biomarkers for specific diseases; scientific research analysis services for blood and other bodily fluids, specifically, blood, bodily fluid, and biological specimen analysis services; scientific, technological, and medical research and data analysis services in the nature of bioanalytical testing services and biomarker discovery services; scientific and medical research in the fields of oncology, mass spectrometry, glycoproteomics, biomarker discovery; scientific, technological, and data analysis services, namely, glycoproteomic research, analysis services in the nature of protein, and a glycoproteomic solution featuring artificial intelligence; scientific and medical laboratory services; medical research services via collecting, analyzing, and reporting glycoproteomic data for blood, bodily fluids, and other biological specimens

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 29, 2023
Primary Code042
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023

Trademark Owner History


Party NameVenn Biosciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameVenn Biosciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Saturday, January 7, 2023NEW APPLICATION ENTERED
Tuesday, September 19, 2023PRIORITY ACTION E-MAILED
Sunday, January 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Tuesday, September 19, 2023PRIORITY ACTION WRITTEN
Tuesday, September 19, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, September 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, July 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 8, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, January 8, 2025SOU EXTENSION 2 FILED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 5, 2025USE AMENDMENT FILED
Wednesday, March 5, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, May 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 8, 2025SOU EXTENSION 2 GRANTED
Sunday, July 21, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 21, 2024SOU EXTENSION 1 FILED